EVOMODUL

Pharmaceuticals for the prevention and/or treatment of cardiovascular diseases; anti-diabetic pharmaceuticals including those covering the vascular complications of diabetes; pharmaceuticals for the treatment of vasculites; pharmaceuticals for the treatment of non-infectious uveites; pharmaceuticals for the prevention and/or treatment of autoimmune and inflammatory diseases; pharmaceuticals for the prevention and/or treatment of inflammatory diseases in the ophthalmological, rheumatic, venous, dermatological and kidney-heart-metabolic fields